Ophthalmologist Randy Epstein, MD, performed the procedure. Dr. Epstein is CEO of Chicago Cornea Consultants.
The newly approved IOLs are designed to improve patients’ distance, intermediate and near vision after surgery. Alcon commercially launched the IOLs in the U.S. in late August.
More articles on supply chain:
‘Don’t re-invent the wheel’: A message for ASC supply chain leaders
Ospitek releases new ASC software
3 ways to ensure smooth adoption of new ASC technology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.